BRAF and melanoma: It appears counter-intuitive that positive BRAF status may be associated with a negative prognosis, if the presence of BRAF mutations in melanoma closely correlates with a younger age of patients, a well-documented positive prognostic factor in stage I–III melanoma (2,37–39).